Glaucoma Surgery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product (Punches, USC marker, USC planner, USC shaver, forceps, algerbrush, probes, diamond knives, Glaucoma Drainage Device, Laser System, Others), By Surgery Method (Traditional glaucoma surgery, Minimal invasive glaucoma surgery, Laser surgery), By End Use (Hospitals, Ophthal
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationGlaucoma Surgery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product (Punches, USC marker, USC planner, USC shaver, forceps, algerbrush, probes, diamond knives, Glaucoma Drainage Device, Laser System, Others), By Surgery Method (Traditional glaucoma surgery, Minimal invasive glaucoma surgery, Laser surgery), By End Use (Hospitals, Ophthal
| Forecast Period | 2024-2028 |
| Market Size (2022) | USD 1.44 billion |
| CAGR (2023-2028) | 5.14% |
| Fastest Growing Segment | Hospitals |
| Largest Market | North America |
Market Overview
Global Glaucoma Surgery Devices Market has valued at USD 1.44 billion in 2022 with a CAGR of 5.14% through 2028. The Global Glaucoma Surgery Devices Market is characterized by a dynamic landscape driven by the increasing prevalence of glaucoma, a leading cause of irreversible blindness. This market encompasses a range of surgical devices and procedures designed to lower intraocular pressure and prevent optic nerve damage. As the aging population grows and eye-related disorders become more prevalent, the demand for effective glaucoma treatment options, including surgical interventions, is on the rise. Furthermore, technological advancements and innovations in minimally invasive surgical techniques are shaping the market's evolution. Key players in the industry are focusing on product development and strategic collaborations to address the unmet medical needs of glaucoma patients and improve the efficacy and safety of surgical procedures.
Key Market Drivers
Increasing geriatric population
The Global Glaucoma Surgery Devices Market is strongly influenced by the increasing geriatric population worldwide. This demographic shift is a significant driver for several reasons. Glaucoma is primarily an age-related eye disease, with the risk of developing the condition increasing significantly after the age of 60. As the global population ages, the prevalence of glaucoma cases rises, leading to a greater demand for effective treatment options, including surgical interventions. The elderly are more susceptible to various eye conditions, including glaucoma. With the geriatric cohort expanding, there is a parallel increase in the overall burden of glaucoma cases. This drives the need for advanced and efficient glaucoma surgery devices to manage the condition. Improved healthcare and medical advancements have extended the average life expectancy globally. While this is a positive development, it also means that individuals are at a higher risk of age-related diseases like glaucoma, necessitating timely diagnosis and treatment. Many developed and developing countries are experiencing a demographic shift toward older populations. This demographic transition, coupled with increasing urbanization, contributes to the prevalence of glaucoma and the demand for surgical interventions.
Glaucoma can lead to vision impairment or blindness, affecting the quality of life and increasing healthcare costs. As governments and healthcare systems strive to address the economic burden associated with glaucoma-related vision loss, investment in glaucoma surgery devices becomes more critical. The rise in the elderly population has spurred innovations in glaucoma surgery techniques and devices. Surgeons are increasingly adopting minimally invasive procedures, such as micro-invasive glaucoma surgery (MIGS), to provide safer and more effective options for older patients. In conclusion, the increasing geriatric population is a pivotal driver of the Global Glaucoma Surgery Devices Market. This demographic trend not only amplifies the prevalence of glaucoma but also underscores the importance of advanced surgical devices and procedures to effectively manage and treat this vision-threatening condition in older individuals. As the aging population continues to grow, the demand for innovative glaucoma surgery solutions is expected to remain robust.
Growing adoption of surgical treatments for glaucoma
The Global Glaucoma Surgery Devices Market is experiencing significant growth due to the growing adoption of surgical treatments for glaucoma. This trend is driven by a confluence of factors that collectively highlight the increasing preference for surgical interventions in managing this sight-threatening condition. Firstly, surgical treatments have gained traction as effective options for glaucoma management. While medications and laser therapies remain important, they may not provide long-term control over intraocular pressure (IOP), a key factor in glaucoma progression. Surgical procedures, on the other hand, offer a more durable solution by creating new drainage pathways or reducing IOP through various mechanisms. As a result, both ophthalmologists and patients are increasingly turning to surgical options to achieve better and more sustainable outcomes. Secondly, advancements in surgical techniques and technologies have enhanced the safety and efficacy of glaucoma surgeries. Minimally invasive glaucoma surgery (MIGS) procedures, for example, have gained popularity as they offer a safer and less invasive alternative to traditional surgeries, reducing the risk of complications and improving patient comfort.
Rising number of government and non-government glaucoma care
The Global Glaucoma Surgery Devices Market is witnessing substantial growth, partly attributed to the increasing number of government and non-government initiatives focused on glaucoma care and awareness. These initiatives play a pivotal role in driving market expansion for several compelling reasons. Firstly, glaucoma is often referred to as the "silent thief of sight" because it can progress without noticeable symptoms until significant vision loss occurs. Governments and non-governmental organizations (NGOs) recognize the importance of early detection and treatment to prevent irreversible blindness caused by glaucoma. As a result, they invest in awareness campaigns, screening programs, and public education to encourage regular eye check-ups and early diagnosis. Secondly, these initiatives emphasize the significance of timely and effective treatment, which often includes surgical interventions for advanced cases. By promoting the availability and accessibility of surgical options, governments and NGOs contribute to the growing adoption of glaucoma surgery devices.
Thirdly, collaborations between healthcare institutions, professionals, and organizations facilitate the dissemination of best practices in glaucoma care. This includes the promotion of advanced surgical techniques and technologies, such as minimally invasive glaucoma surgery (MIGS), which are safer and more accessible to a wider range of patients. Moreover, the economic burden associated with untreated glaucoma is a driving force behind these initiatives. Vision loss can lead to increased healthcare costs, reduced productivity, and a diminished quality of life for affected individuals. Governments and NGOs recognize that investing in glaucoma care, including surgical treatments, can alleviate this economic burden in the long run.
Growing prevalence of diabetes
The Global Glaucoma Surgery Devices Market is experiencing an upsurge in growth due to the growing prevalence of diabetes, a major risk factor for glaucoma. This intricate connection between diabetes and glaucoma underscores the impact of the rising diabetes epidemic on the market. Firstly, individuals with diabetes are at an elevated risk of developing glaucoma. Diabetic patients often experience fluctuations in blood sugar levels, which can lead to damage to the blood vessels in the eye, ultimately increasing the risk of glaucoma. As the global diabetes population surges, so does the pool of individuals susceptible to glaucoma, driving the demand for effective treatment options, including surgical interventions. Secondly, diabetes-related eye complications, such as diabetic retinopathy, can exacerbate glaucoma or complicate its management. This comorbidity necessitates comprehensive eye care, often involving surgical procedures to address both conditions simultaneously. As diabetes-related eye issues become more prevalent, there is a growing need for advanced glaucoma surgery devices to cater to these complex cases.
Thirdly, the aging population is at a higher risk of both diabetes and glaucoma, creating a demographic convergence that amplifies the prevalence of both conditions. This demographic trend is further exacerbated by lifestyle factors, including sedentary lifestyles and poor dietary habits, which contribute to the diabetes epidemic. Moreover, the economic burden associated with diabetes-related eye diseases, including glaucoma, drives governments, healthcare systems, and medical institutions to prioritize the availability and accessibility of advanced surgical interventions. This leads to increased investments in glaucoma surgery devices and technologies to address the growing healthcare demands. In conclusion, the growing prevalence of diabetes is a significant driver of the Global Glaucoma Surgery Devices Market. The intricate relationship between diabetes and glaucoma, coupled with the increasing burden of diabetes worldwide, fuels the demand for innovative surgical solutions and devices to effectively manage glaucoma in diabetic individuals, driving market growth and innovation in the field.
Key Market Challenges
Availability of alternative treatment methods
Secondly, laser therapy, particularly selective laser trabeculoplasty (SLT) and laser peripheral iridotomy (LPI), is another non-surgical approach to lowering IOP. These procedures are less invasive and typically involve shorter recovery times compared to surgical interventions, making them appealing alternatives for patients. Thirdly, the emergence of minimally invasive glaucoma surgery (MIGS) has provided a middle ground between medication and traditional glaucoma surgeries. MIGS procedures are less traumatic and can often be combined with cataract surgery, reducing the need for separate interventions. Additionally, patient factors such as age, overall health, and disease severity play a crucial role in treatment selection. Ophthalmologists must consider these factors when recommending treatment options, and non-surgical approaches may be preferred in certain cases.
Lack of awareness about glaucoma and its treatment procedures in underdeveloped
The lack of awareness about glaucoma and its treatment procedures in underdeveloped regions poses a significant challenge to the Global Glaucoma Surgery Devices Market. This challenge is multifaceted and affects various aspects of glaucoma care and device adoption. Firstly, underdeveloped regions often face a dearth of accessible healthcare infrastructure, including eye care facilities and ophthalmologists. This limited healthcare infrastructure impedes early glaucoma diagnosis and comprehensive patient education, as individuals may not have easy access to regular eye check-ups or eye health information.
Secondly, the lack of awareness about glaucoma as a "silent" eye disease means that patients often seek medical attention only when the condition is in advanced stages. This delays the initiation of treatment, including surgical interventions, and may result in poorer outcomes. Thirdly, surgical treatments for glaucoma can be intimidating for patients, especially in regions with low awareness and limited access to information. Fear of surgery and lack of understanding about its benefits can deter individuals from considering surgical options, further delaying timely interventions. Additionally, healthcare disparities in underdeveloped regions can lead to unequal access to surgical treatments. Patients from disadvantaged backgrounds may face financial barriers or lack insurance coverage for glaucoma surgeries, limiting their ability to undergo these procedures. Moreover, ophthalmologists and healthcare providers in underdeveloped regions may have limited exposure to the latest advancements in glaucoma surgery devices and procedures. This can result in suboptimal patient care, as clinicians may not be aware of or have access to the most effective surgical options.
Key Market Trends
Minimally Invasive Glaucoma Surgery (MIGS) Dominance
The dominance of Minimally Invasive Glaucoma Surgery (MIGS) represents a significant and transformative trend in the Global Glaucoma Surgery Devices Market. This trend is driven by a combination of factors that collectively underscore the growing preference for MIGS procedures among ophthalmologists and patients. Firstly, MIGS procedures are characterized by their less invasive nature compared to traditional glaucoma surgeries. They typically involve smaller incisions, reduced trauma to eye tissues, and shorter recovery times. This makes them appealing to patients who are seeking effective glaucoma treatment with minimal disruption to their daily lives.
Secondly, the safety profile of MIGS procedures is a compelling factor. With lower risk of complications such as infection or bleeding, MIGS enhances patient comfort and satisfaction. Ophthalmologists are also drawn to the reduced surgical risk and improved safety profile, making them more inclined to recommend MIGS to their patients. Thirdly, MIGS procedures are often performed in conjunction with cataract surgery, addressing both conditions simultaneously. Given the high prevalence of both glaucoma and cataracts in the aging population, this combination approach offers efficiency and convenience for patients and surgeons alike. Moreover, MIGS procedures have demonstrated their ability to provide sustained intraocular pressure (IOP) reduction, which is a crucial goal in glaucoma management. This efficacy, combined with the minimally invasive nature of MIGS, positions these procedures as attractive options for a broad range of glaucoma patients, from early to more advanced stages.
Furthermore, regulatory agencies have expedited approvals for MIGS devices, encouraging innovation and market entry. This has led to a proliferation of MIGS options and a competitive landscape that fosters continuous improvement. In summary, the dominance of MIGS in the Global Glaucoma Surgery Devices Market is driven by its minimally invasive nature, safety, efficacy, and compatibility with cataract surgery. These factors collectively reflect a trend toward patient-centered care and enhanced surgical options, making MIGS a transformative force in glaucoma treatment. As MIGS continues to evolve and expand, it is expected to play a central role in shaping the future of glaucoma management.
Advanced Implantable Devices
Advanced implantable devices represent a significant trend in the Global Glaucoma Surgery Devices Market, reshaping the landscape of glaucoma treatment. These devices are designed to provide sustained and precise intraocular pressure (IOP) control, offering several key advantages. Firstly, advanced implantable devices, such as microstents and shunts, provide a long-term solution for managing glaucoma. They create alternative pathways for aqueous humor drainage, reducing IOP and slowing the progression of the disease. This sustained control often means reduced dependence on medications and fewer visits for follow-up treatments, enhancing the patient's quality of life. Secondly, these devices offer a more predictable and customizable approach to glaucoma management. Surgeons can tailor the placement and configuration of these implants to suit individual patient needs, optimizing outcomes and minimizing side effects.
Thirdly, advanced implantable devices are often compatible with minimally invasive procedures, such as Minimally Invasive Glaucoma Surgery (MIGS). This combination approach allows for effective treatment while minimizing trauma to eye tissues and expediting recovery. Furthermore, the development and refinement of these implantable devices continue to drive innovation in the glaucoma surgery field. Manufacturers are investing in research and development to enhance the safety, efficacy, and durability of these devices, positioning them as a promising trend in glaucoma care. In summary, the trend toward advanced implantable devices in the Global Glaucoma Surgery Devices Market is revolutionizing glaucoma treatment. These devices offer sustained IOP control, personalization, and compatibility with minimally invasive procedures, ultimately benefiting patients by providing effective, long-term solutions for this sight-threatening condition.
Segmental Insights
Product Insights
Glaucoma drainage devices emerged as the dominant segment in the Global Glaucoma Surgery Devices Market due to several compelling factors. Firstly, glaucoma is a chronic eye condition characterized by increased intraocular pressure (IOP), and effective IOP management is crucial to prevent vision loss. Glaucoma drainage devices play a pivotal role in achieving sustained IOP reduction, making them indispensable in the treatment of this sight-threatening disease. Secondly, the prevalence of glaucoma is rising globally, especially among the aging population. As a result, there is a growing demand for effective glaucoma treatment options, and drainage devices provide a reliable and proven solution for patients at various stages of the disease.
Thirdly, the synergy between cataract and glaucoma surgeries further bolsters the prominence of glaucoma drainage devices. Ophthalmologists frequently perform these procedures in combination, addressing both conditions simultaneously. This dual approach not only enhances patient convenience but also contributes to the increased utilization of glaucoma drainage devices. Furthermore, advancements in the field of Minimally Invasive Glaucoma Surgery (MIGS) have launched innovative devices like iStent, which have gained regulatory approvals and contributed significantly to the segment's growth. These MIGS drainage devices offer minimally invasive alternatives, reducing surgical trauma and improving patient outcomes. In summary, glaucoma drainage devices have secured the largest market share due to their effectiveness in managing IOP, rising glaucoma prevalence, the synergy with cataract surgeries, and the introduction of innovative MIGS devices. These factors collectively position them as a cornerstone in the treatment of glaucoma and the driving force behind the segment's dominance in the market.
Surgery Method Insights
The traditional glaucoma surgery segment's dominance in the Global Glaucoma Surgery Devices Market can be attributed to several significant factors. Firstly, traditional glaucoma surgeries, such as trabeculectomy and tube shunt implantation, have a long-established track record of effectively reducing intraocular pressure (IOP) and managing glaucoma. Ophthalmologists have relied on these procedures for decades to treat patients with various stages of the disease. Secondly, despite the emergence of Minimally Invasive Glaucoma Surgery (MIGS) options, traditional surgeries continue to be the preferred choice in cases of advanced or complex glaucoma. They offer a high degree of IOP control and are particularly valuable when more conservative approaches have proven ineffective.
Thirdly, traditional glaucoma surgeries are considered the gold standard for achieving significant and sustained IOP reduction. This is particularly crucial in cases where preserving vision and preventing further optic nerve damage are top priorities. Furthermore, the traditional glaucoma surgery segment's market share is bolstered by a wealth of clinical experience, well-established surgical techniques, and a robust body of research supporting their efficacy. These factors collectively position traditional glaucoma surgeries as the cornerstone of glaucoma management, explaining their continued dominance in the market.
Regional Insights
North America's dominance in the Global Glaucoma Surgery Devices Market can be attributed to several key factors. Firstly, the region boasts a well-established healthcare infrastructure, including advanced eye care facilities and a highly skilled workforce of ophthalmologists and eye surgeons. This robust healthcare ecosystem ensures timely access to glaucoma diagnosis and treatment, which significantly contributes to the market's growth. Secondly, North America has a substantial geriatric population, and glaucoma predominantly affects older individuals. The prevalence of glaucoma increases with age, and as the region experiences demographic shifts towards an aging population, the demand for glaucoma surgery devices naturally rises.
Thirdly, the region is characterized by a high level of healthcare expenditure and research and development activities. This fosters innovation in glaucoma surgical techniques and device development, leading to the introduction of advanced and cutting-edge solutions. The regulatory framework in North America is conducive to the approval and adoption of new technologies and devices, further propelling market growth. Moreover, North America has a strong focus on patient care, awareness campaigns, and regular eye check-ups, which promote early diagnosis and intervention for glaucoma patients. All these factors collectively position North America as the dominant market for glaucoma surgery devices, and its leadership in the field is expected to persist in the foreseeable future.
Download Free Sample Report
Recent Developments
- In January 2022, Alcon, a global leader in visioncare, announced its acquisition of Aerie Pharmaceuticals, Inc. This transactionhelped bolster Alcon’s presence in the ophthalmic pharmaceutical space with itsgrowing portfolio of commercial products and development pipeline.
- In October 2022, Alcon completed Acquisition ofIvantis, Inc., Bringing Hydrus Microstent into Its global surgical portfolio aminimally invasive glaucoma surgery (MIGS) device designed to lower eyepressure for open-angle glaucoma patients in connection with cataract surgery.
Key Market Players
- Alcon, Inc.
- AbbottMedical Optics Pvt Ltd
- Asico LLC
- KatalystSurgical LLC
- ZiemerOphthalmic Systems AG
- LumenisLtd
- IridexCorporation
- CarlZeiss Meditec AG
- AllerganPlc.
- GlaukosCorporation
| By Product | By Surgery Method | By End Use | By Region |
|
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy